Clinical Trial Update: StaphVAX in Cardiovascular Surgery Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating StaphVAX in cardiovascular surgery patients has completed. The trial assessed outcomes related to preventing Staphylococcus aureus in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Staphylococcal Infections

Drugs mentioned

• StaphVAX

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections, Cardiovascular Diseases | Phase 3 | Status: COMPLETED